Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+6.83M
-
Total reported value, excl. options
-
$3.75B
-
Value change
-
+$217M
-
Put/Call ratio
-
1.04
-
Number of buys
-
116
-
Number of sells
-
-98
-
Price
-
$31.81
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q3 2016
282 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q3 2016.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 170M outstanding shares and own 69.27% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (25.8M shares), FMR LLC (18.1M shares), VANGUARD GROUP INC (6.87M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.72M shares), OppenheimerFunds, Inc. (5.15M shares), FRANKLIN RESOURCES INC (4.18M shares), Capital World Investors (3.76M shares), JANUS CAPITAL MANAGEMENT LLC (3.2M shares), STATE STREET CORP (3.11M shares), and BlackRock Fund Advisors (2.55M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.